300 related articles for article (PubMed ID: 29336269)
41. Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
Sahin Z; Ertas M; Berk B; Biltekin SN; Yurttas L; Demirayak S
Bioorg Med Chem; 2018 May; 26(8):1986-1995. PubMed ID: 29525337
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
43. Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
Diaz de Greñu B; Fernández-Aroca DM; Organero JA; Durá G; Jalón FA; Sánchez-Prieto R; Ruiz-Hidalgo MJ; Rodríguez AM; Santos L; Albasanz JL; Manzano BR
J Biol Inorg Chem; 2023 Sep; 28(6):531-547. PubMed ID: 37458856
[TBL] [Abstract][Full Text] [Related]
44. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors.
Ammazzalorso A; Gallorini M; Fantacuzzi M; Gambacorta N; De Filippis B; Giampietro L; Maccallini C; Nicolotti O; Cataldi A; Amoroso R
Eur J Med Chem; 2021 Feb; 211():113115. PubMed ID: 33360796
[TBL] [Abstract][Full Text] [Related]
46. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
47. New benzothienopyrimidine derivatives as dual EGFR/ARO inhibitors: Design, synthesis, and their cytotoxic effect on MCF-7 breast cancer cell line.
Sobh EA; Khalil NA; Faggal SI; Hassan MSA
Drug Dev Res; 2022 Aug; 83(5):1075-1096. PubMed ID: 35286757
[TBL] [Abstract][Full Text] [Related]
48. Exploring new chemical functionalities to improve aromatase inhibition of steroids.
Varela CL; Amaral C; Correia-da-Silva G; Costa SC; Carvalho RA; Costa G; Alcaro S; Teixeira NA; Tavares-da-Silva EJ; Roleira FM
Bioorg Med Chem; 2016 Jun; 24(12):2823-31. PubMed ID: 27160054
[TBL] [Abstract][Full Text] [Related]
49. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
[TBL] [Abstract][Full Text] [Related]
50. The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
Lu WJ; Xu C; Pei Z; Mayhoub AS; Cushman M; Flockhart DA
Breast Cancer Res Treat; 2012 May; 133(1):99-109. PubMed ID: 21814747
[TBL] [Abstract][Full Text] [Related]
51. Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
Zhou N; Han SY; Zhou F; Li PP
J Ethnopharmacol; 2014 Jul; 154(3):687-95. PubMed ID: 24809288
[TBL] [Abstract][Full Text] [Related]
52. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
Muftuoglu Y; Mustata G
Bioorg Med Chem Lett; 2010 May; 20(10):3050-64. PubMed ID: 20413308
[TBL] [Abstract][Full Text] [Related]
53. Azoles additively inhibit cytochrome P450 1 (EROD) and 19 (aromatase) in rainbow trout (Oncorhynchus mykiss).
Beijer K; Jönsson M; Shaik S; Behrens D; Brunström B; Brandt I
Aquat Toxicol; 2018 May; 198():73-81. PubMed ID: 29522952
[TBL] [Abstract][Full Text] [Related]
54. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
[TBL] [Abstract][Full Text] [Related]
56. 2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.
Lézé MP; Le Borgne M; Marchand P; Loquet D; Kogler M; Le Baut G; Palusczak A; Hartmann RW
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):549-57. PubMed ID: 15662958
[TBL] [Abstract][Full Text] [Related]
57. Novel aromatase inhibitors by structure-guided design.
Ghosh D; Lo J; Morton D; Valette D; Xi J; Griswold J; Hubbell S; Egbuta C; Jiang W; An J; Davies HM
J Med Chem; 2012 Oct; 55(19):8464-76. PubMed ID: 22951074
[TBL] [Abstract][Full Text] [Related]
58. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
[TBL] [Abstract][Full Text] [Related]
60. [Establishment of an aromatase inhibitor letrozole-resistant breast cancer cell model].
Chen HY; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):423-8. PubMed ID: 24119901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
